Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Huntington Bancshares Incorporated (HBAN) Price & Performance

Acadia Healthcare Company IncTrade
Huntington Bancshares IncorporatedTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs Huntington Bancshares Incorporated — how do they compare? Acadia Healthcare Company Inc trades at $31.86 (market cap $2.90B), while Huntington Bancshares Incorporated trades at $17.79 (market cap $35.93B). The key difference: Huntington Bancshares Incorporated is far larger — about 12.4× Acadia Healthcare Company Inc's market cap, and Huntington Bancshares Incorporated pays a 3.49% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCHBAN
Market Cap
$2.90B$35.93B
Sector
HealthFinancials
52-Week High
$35.61$19.27
52-Week Low
$11.68$15.02
Enterprise Value
$5.29B
Dividend Yield
3.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.14, down 2.01% today, with a neutral technical signal and mixed fundamentals. The company reported Q2 2026 EPS of $0.38, beating estimates, but maintains a net loss of -$1.10B for 2025. Analyst consensus is bullish with a $36.00 price target, though ongoing legal investigations and negative profit margins present headwinds. Cash flow from operations improved to $211M in 2026, supporting operational stability amid challenges.

The outlook for ACHC hinges on execution of its turnaround strategy and resolution of legal issues. Upside potential exists if EBITDA guidance improvements and admissions growth persist, but risks from litigation and sustained losses warrant caution. The stock's current valuation at a P/E of 19.82 and P/S of 0.84 may attract value investors if profitability recovers.

Huntington Bancshares Incorporated

Huntington Bancshares (HBAN) trades at $17.82, up 1.25% recently, with a bullish technical outlook and mixed earnings history. The company reported Q2 2026 EPS of $0.33, missing estimates, but revenue growth to $8.13B in 2025 supports a net income margin of 24.77%. Analysts maintain a consensus price target of $19.78, with 45% recommending Buy, amid concerns over rising deposit costs noted in recent news.

HBAN offers potential upside with a reasonable P/E of 13.68 and dividend yield, but faces risks from expense pressures and competitive banking dynamics. The stock's outlook hinges on execution of its ROTCE target of 18-19% by 2027, balancing growth opportunities with macroeconomic headwinds.

Returns comparison

Trailing returns across standard periods

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Huntington Bancshares Incorporated

Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.

Read more on HBAN